Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01499381 · ClinicalTrials.gov registry record
EMBRACE1: Prostate Biorepository
A clinical trial, sponsored by Caris Science.
- Completed
- Registry status
- 1,290
- Enrollment target
NCT01499381 is a clinical trial that has completed, run by Caris Science. The registered enrollment target is 1,290 participants.
The verdict
NCT01499381 has completed, sponsored by Caris Science.
- COMPLETED
- Registry status
- 1,290 participants
- Enrollment target
Study Summary
The objective of this multi-center prospective observational clinical study is to evaluate the clinical performance of the Carisome Prostate assay as an aid in the diagnosis of prostate cancer in men that have been scheduled for a prostate biopsy. Primarily, results of the Carisome Prostate assay will be compared with pathology results of prostate biopsy procedures. Secondarily, the performance of the Carisome Prostate test will be compared to the current standard of care for the detection of prostate cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,290 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01499381
The ClinicalTrials.gov registry entry for NCT01499381 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Caris Science, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01499381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01499381 about?
NCT01499381 is a clinical study titled "EMBRACE1: Prostate Biorepository". The objective of this multi-center prospective observational clinical study is to evaluate the clinical performance of the Carisome Prostate assay as an aid in the diagnosis of prostate cancer in men that have been scheduled for a prostate biopsy. Primarily, results of the Carisome Prostate assay wi...
What is the current status of trial NCT01499381?
This trial is currently completed. The enrollment target is 1,290 participants. The study started on 2011-12. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01499381?
This trial is sponsored by Caris Science, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.